Clinical Trial Update: The Effect of Colchicine on Inflammation in ACS Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating colchicine for inflammation in acute coronary syndrome, including STEMI, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• St-segment Elevation Myocardial Infarction

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Ain Shams University | Conditions: Acute Coronary Syndrome, STEMI | Phase 3 | Status: COMPLETED